Inhibrx Common Stock Shares Outstanding from 2010 to 2025

INBX Stock  USD 13.49  0.05  0.37%   
Inhibrx Common Stock Shares Outstanding yearly trend continues to be fairly stable with very little volatility. Common Stock Shares Outstanding will likely drop to about 38.2 M in 2025. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2018-03-31
Previous Quarter
14.8 M
Current Value
15.5 M
Quarterly Volatility
9.8 M
 
Covid
Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 38.4 M, Minority Interest of 0.0 or Tax Provision of 2.6 K, as well as many indicators such as Price To Sales Ratio of 940, Dividend Yield of 0.0021 or PTB Ratio of 38.9. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.
  
Check out the analysis of Inhibrx Correlation against competitors.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Latest Inhibrx's Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of Inhibrx over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Inhibrx's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

Inhibrx Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean33,551,672
Geometric Mean32,752,930
Coefficient Of Variation24.29
Mean Deviation6,608,340
Median28,789,000
Standard Deviation8,148,932
Sample Variance66.4T
Range28.9M
R-Value0.72
Mean Square Error33.8T
R-Squared0.52
Significance0
Slope1,240,052
Total Sum of Squares996.1T

Inhibrx Common Stock Shares Outstanding History

202538.2 M
202454.2 M
202347.1 M
202240.1 M
202138 M
202025.3 M
201936.6 M

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding54.2 M38.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.